Product Program year 2019 Source: CMS Open Payments

Disease State

Drug

Open in the dashboard

General payments

$1,099,876

1,851 payments

Research payments

$0

0 payments

Through program year 2019, $1,099,876 in general payments and $0 in research payments were reported against Disease State.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $1,099,876 1,851

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $608,002 967 payments
  2. Sanofi-Aventis U.S. LLC $471,320 838 payments
  3. Sanofi Pasteur Inc. $20,553 46 payments
Top recipients General payments · program year 2019
  1. Annette Howard Neurology · Houston, TX $20,958 2% · 18 payments
  2. Suhayl Dhib-Jalbut Neurology · New Brunswick, NJ $17,908 2% · 15 payments
  3. Ramin Tolouian Nephrology · Norfolk, VA $17,698 2% · 15 payments
  4. Kenneth Berger Pulmonary Disease · New York, NY $16,764 2% · 14 payments
  5. Aram Zabeti Neurology · Cincinnati, OH $16,348 1% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Neurology Psychiatry & Neurology $369,960 34% · 194 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $169,035 16% · 102 practitioners
  3. Cardiovascular Disease Internal Medicine $101,906 9% · 107 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $59,481 6% · 26 practitioners
  5. Internal Medicine $56,355 5% · 140 practitioners

The top 5 of 89 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Texas $125,548 11% · 150 recipients
  2. Pennsylvania $105,503 10% · 61 recipients
  3. Ohio $93,381 8% · 41 recipients
  4. New York $84,320 8% · 63 recipients
  5. Florida $78,820 7% · 95 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

1,851 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record